Skip to main content

Advertisement

Log in

Deep Venous Thrombosis and Pulmonary Embolism are Uncommon in East Asian Patients after Total Hip Arthroplasty

  • Clinical Research
  • Published:
Clinical Orthopaedics and Related Research®

Abstract

Background

In Western countries, deep vein thrombosis (DVT) and pulmonary embolism (PE), are relatively common after THA and many surgeons recommend routine pharmacologic thromboprophylaxis. There is some suggestion in the literature that the incidences of DVT and PE may be lower in East Asian patients. Therefore, it would be important to establish the incidences in a large number of East Asian patients who did not receive pharmacologic thromboprophylaxis.

Purpose

We therefore determined the incidence of DVT and PE and evaluated the associated risk factors in a series of East Asian patients who underwent primary THA without pharmacologic prophylaxis.

Methods

We retrospectively evaluated all 861 patients who underwent 992 elective primary THAs from May 2003 to December 2009. We identified patients with symptomatic DVT, symptomatic PE, and fatal PE. For potential risk factors we considered age, gender, body mass index (BMI), administration of aspirin, type of anesthesia, operation time, approach, simultaneous bilateral THAs, and duration of immobilization between symptomatic and asymptomatic patients.

Results

We identified eight patients with symptomatic DVT, one of whom also had a symptomatic PE; there were no cases of fatal PE. The incidences of fatal PE, symptomatic PE, and symptomatic DVT were 0 %, 0.1 %, and 0.8 %, respectively. Longer duration of immobilization predicted symptomatic DVT or PE.

Conclusions

East Asian patients have a low incidence of symptomatic DVT and PE and virtually no fatal PEs after primary THA. The incidences and risk factors should be taken into consideration when deciding whether to prophylactically treat these patients with pharmacologic agents.

Level of Evidence

Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1A–C

Similar content being viewed by others

References

  1. Albrechtsson U, Olsson CG. Thrombotic side-effects of lower-limb phlebography. Lancet. 1976;1:723–724.

    Article  PubMed  CAS  Google Scholar 

  2. Bagaria V, Modi N, Panghate A, Vaidya S. Incidence and risk factors for development of venous thromboembolism in Indian patients undergoing major orthopaedic surgery: results of a prospective study. Postgrad Med J. 2006;82:136–139.

    Article  PubMed  CAS  Google Scholar 

  3. Bettmann MA, Robbins A, Braun SD, Wetzner S, Dunnick NR, Finkelstein J. Contrast venography of the leg: diagnostic efficacy, tolerance, and complication rates with ionic and nonionic contrast media. Radiology. 1987;165:113–116.

    PubMed  CAS  Google Scholar 

  4. Burnett RS, Clohisy JC, Wright RW, McDonald DJ, Shively RA, Givens SA, Barrack RL. Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty. 2007;22:317–324.

    Article  PubMed  Google Scholar 

  5. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, Schwartz JS, Thompson BT, Popovich J Jr, Hobbins TE, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240–1245.

    Article  PubMed  CAS  Google Scholar 

  6. Clagett GP, Anderson FA Jr, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest. 1995;108(4 suppl):312S–334S.

    Article  PubMed  CAS  Google Scholar 

  7. Cohen AT, Skinner JA, Kakkar VV. Antiplatelet treatment for thromboprophylaxis: a step forward or backwards? BMJ. 1994;309:1213–1215.

    Article  PubMed  CAS  Google Scholar 

  8. Coventry MB, Nolan DR, Beckenbaugh RD. “Delayed” prophylactic anticoagulation: a study of results and complications in 2,012 total hip arthroplasties. J Bone Joint Surg Am. 1973;55:1487–1492.

    PubMed  CAS  Google Scholar 

  9. Dhillon KS, Askander A, Doraismay S. Postoperative deep-vein thrombosis in Asian patients is not a rarity: a prospective study of 88 patients with no prophylaxis. J Bone Joint Surg Br. 1996;78:427–430.

    PubMed  CAS  Google Scholar 

  10. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW; Ammerican College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 suppl):381S–453S.

    Article  PubMed  CAS  Google Scholar 

  11. Huber O, Bounameaux H, Borst F, Rohner A. Postoperative pulmonary embolism after hospital discharge: an underestimated risk. Arch Surg. 1992;127:310–313.

    PubMed  CAS  Google Scholar 

  12. Kakkar VV, Stringer MD. Prophylaxis of venous thromboembolism. World J Surg. 1990;14:670–678.

    Article  PubMed  CAS  Google Scholar 

  13. Kim YH, Kim JS. The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors. Clin Orthop Relat Res. 2007;465:33–39.

    PubMed  Google Scholar 

  14. Kim YH, Suh JS. Low incidence of deep-vein thrombosis after cementless total hip replacement. J Bone Joint Surg Am. 1988;70:878–882.

    PubMed  CAS  Google Scholar 

  15. Klatsky AL, Armstrong MA, Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol. 2000;85:1334–1337.

    Article  PubMed  CAS  Google Scholar 

  16. Leizorovicz A. Epidemiology of post-operative venous thromboembolism in Asian patients: results of the SMART venography study. Haematologica. 2007;92:1194–1200.

    Article  PubMed  Google Scholar 

  17. Leizorovicz A, Turpie AG, Cohen AT, Wong L, Yoo MC, Dans A; SMART Study Group. Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis: the SMART study. J Thromb Haemost. 2005;3:28–34.

    Article  PubMed  CAS  Google Scholar 

  18. May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8:419–427.

    Article  PubMed  CAS  Google Scholar 

  19. Memtsoudis SG, Besculides MC, Gaber L, Liu S, Gonzalez Della Valle A. Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study. Int Orthop. 2009;33:1739–1745.

    Article  PubMed  Google Scholar 

  20. Miric A, Lombardi P, Sculco TP. Deep vein thrombosis prophylaxis: a comprehensive approach for total hip and total knee arthroplasty patient populations. Am J Orthop (Belle Mead NJ). 2000;29:269–274.

    CAS  Google Scholar 

  21. Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty. 2010;25:64–70.

    Article  PubMed  Google Scholar 

  22. Paiement GD, Wessinger SJ, Hughes R, Harris WH. Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement. J Bone Joint Surg Am. 1993;75:893–898.

    PubMed  CAS  Google Scholar 

  23. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156–2164.

    Article  PubMed  CAS  Google Scholar 

  24. Pellegrini VD Jr, Clement D, Lush-Ehmann C, Keller GS, Evarts CM. The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 1996;333:27–40.

    Article  PubMed  Google Scholar 

  25. Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, Turpie AG, Gallus AS, Planes A, Passera R, Rouillon A; AIDA investigators. Deep-vein thrombosis rates after major orthopedic surgery in Asia: an epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost. 2005;3:2664–2670.

    Article  PubMed  CAS  Google Scholar 

  26. Price MJ. Monitoring platelet function to reduce the risk of ischemic and bleeding complications. Am J Cardiol. 2009;103(3 suppl):35A–39A.

    Article  PubMed  CAS  Google Scholar 

  27. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet. 1995;346:1133–1134.

    Article  PubMed  CAS  Google Scholar 

  28. Samama CM, Ravaud P, Parent F, Barre J, Mertl P, Mismetti P. Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study. J Thromb Haemost. 2007;5:2360–2367.

    Article  PubMed  CAS  Google Scholar 

  29. Schulman S, Beyth RJ, Kearon C, Levine MN; American College of Chest Physicians. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:(6 suppl):257S–298S.

    Article  PubMed  CAS  Google Scholar 

  30. Sikorski JM, Hampson WG, Staddon GE. The natural history and aetiology of deep vein thrombosis after total hip replacement. J Bone Joint Surg Br. 1981;63:171–177.

    PubMed  Google Scholar 

  31. Thomas DP, Roberts HR. Hypercoagulability in venous and arterial thrombosis. Ann Intern Med. 1997;126:638–644.

    PubMed  CAS  Google Scholar 

  32. Warwick D. New concepts in orthopaedic thromboprophylaxis. J Bone Joint Surg Br. 2004;86:788–792.

    Article  PubMed  CAS  Google Scholar 

  33. Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement: a series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br. 1995;77:6–10.

    PubMed  CAS  Google Scholar 

  34. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. J Bone Joint Surg Am. 2002;84:2161–2167.

    PubMed  Google Scholar 

  35. Wroblewski BM, Siney PD, White R. Fatal pulmonary embolism after total hip arthroplasty: seasonal variation. Clin Orthop Relat Res. 1992;276:222–224.

    PubMed  Google Scholar 

  36. Yoo MC, Kang CS, Kim YH, Kim SK. A prospective randomized study on the use of nadroparin calcium in the prophylaxis of thromboembolism in Korean patients undergoing elective total hip replacement. Int Orthop. 1997;21:399–402.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgement

We thank Chong Bum Chang MD for statistical advice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Young-Kyun Lee MD.

Additional information

Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.

Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was waived by the institutional review board of their hospital.

This work was performed at the Department of Orthopaedic Surgery, Seoul National University Bundang Hospital.

About this article

Cite this article

Kang, B.J., Lee, YK., Kim, H.J. et al. Deep Venous Thrombosis and Pulmonary Embolism are Uncommon in East Asian Patients after Total Hip Arthroplasty. Clin Orthop Relat Res 469, 3423–3428 (2011). https://doi.org/10.1007/s11999-011-1979-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-011-1979-7

Keywords

Navigation